SCHEMBL6765131

SCHEMBL6765131

CCC(Oc1ccc(O)cc1)C(=O)OC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MIF P14174 1/20 0.48
ESR1 P03372 3/20 0.45
ESR2 Q92731 3/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
TSHR P16473 4/20 0.43
CYP1A2 P05177 2/20 0.42
CYP2D6 P10635 2/20 0.42
CYP2C19 P33261 2/20 0.42
CYP2C9 P11712 1/20 0.42
AR P10275 1/20 0.41
CA12 O43570 2/20 0.41
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
CA7 P43166 2/20 0.41
CA9 Q16790 2/20 0.41
CA14 Q9ULX7 2/20 0.41
MMP2 P08253 1/20 0.41
MMP9 P14780 1/20 0.41
MMP13 P45452 1/20 0.41
ALDH1A1 P00352 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14378432 1.00 MIF (0.48) MIFESR1ESR2SMN1; SMN2TSHR
SCHEMBL12220660 0.86 SMN1; SMN2 (0.49) SMN1; SMN2TSHRCYP1A2CYP2D6CYP2C19
SCHEMBL21129084 0.85 CYP1A2 (0.56) TSHRCYP1A2CYP2D6CYP2C19CYP2C9
SCHEMBL25997018 0.85 CYP1A2 (0.56) TSHRCYP1A2CYP2D6CYP2C19CYP2C9
SCHEMBL2224275 0.85 PPARG (0.46) ESR1ESR2SMN1; SMN2CYP2C9PPARG
SCHEMBL10938219 0.84 TSHR (0.58) TSHRALDH1A1LMNAPPARGPPARA
SCHEMBL22542322 0.84 SMN1; SMN2 (0.55) MIFSMN1; SMN2TSHRCYP1A2CYP2D6
SCHEMBL7413009 0.83 PPARG (0.51) SMN1; SMN2TSHRCYP1A2CYP2D6CYP2C19
SCHEMBL29384572 0.83 PPARG (0.52) SMN1; SMN2TSHRCYP1A2CYP2D6CYP2C19
SCHEMBL9656236 0.82 SMN1; SMN2 (0.65) SMN1; SMN2PPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6756489-B1 PROTECTED MONOSACCHARIDES HAVING AN ALLYL PROTECTING GROUP, A SILANE-PROTECTED HYDROXY GROUP AND A CARBOXY OR AMIDE CONTAINING PROTECTIVE GROUP; EASILY MADE BY COMBINATORIAL CHEMISTRY; APPLICATIONS TO AUTOIMMUNE AND CANCER AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2004-06-29 US disclosed